The Company projects 2024 revenues to be greater than $3.0 billion, projects 2024 Adjusted EBITDA to be greater than $495 million.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SGRY:
- Is SGRY a Buy, Before Earnings?
- Surgery Partners, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call Details
- Surgery Partners, Inc. Reaffirms 2023 Full Year Guidance and Provides 2024 Initial Adjusted EBITDA Outlook
- Surgery Partners reaffirms FY23 revenue guidance $2.75B, consensus $2.75B
- Surgery Partners, Inc. to Present at Upcoming Investor Conference
